Literature DB >> 16246327

The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.

Gina D Visser1, Nancy L Lill.   

Abstract

Evolutionarily conserved sequences of the E3/protein-ubiquitin ligase Cbl regulate epidermal growth factor receptor (EGF-R) signaling and degradation. These sequences encompass Cbl's tyrosine kinase-binding domain, linker region, RING finger (RF), and an uncharacterized flank C-terminal to the RF (residues 420-436). The latter domain, designated the RF tail, extends beyond Cbl's ubiquitin-conjugating enzyme (Ubc)-binding domain and has no known function. We report structure-function studies evaluating the impact of Cbl RF tail truncations on EGF-R fate in HEK 293 cells. All of the truncation mutants exhibit greatly reduced binding to activated EGF-R and lack proline-rich sequences that mediate direct Cbl association with SH3 proteins such as Grb2, yet a subset of mutants collectively enhances EGF-R ubiquitination, downregulation, and degradation. Significantly, EGF-R degradation correlates better with RF tail-dependent degradation of the Cbl substrate Sprouty2 than with EGF-R ubiquitination: expression of the RF tail truncation mutant Cbl 1-433 enhanced EGF-R ubiquitination while impeding Sprouty2 degradation, and Cbl 1-433 failed to enhance EGF-R downregulation or degradation. Our results suggest that EGF-R fate is controlled by a checkpoint downstream of receptor ubiquitination whose regulation by the Cbl RF tail may require Sprouty2 degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246327     DOI: 10.1016/j.yexcr.2005.09.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Cbl controls EGFR fate by regulating early endosome fusion.

Authors:  Gina D Visser Smit; Trenton L Place; Sara L Cole; Kathryn A Clausen; Soumya Vemuganti; Guojuan Zhang; John G Koland; Nancy L Lill
Journal:  Sci Signal       Date:  2009-12-22       Impact factor: 8.192

2.  Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.

Authors:  Simone Martinelli; Alessandro De Luca; Emilia Stellacci; Cesare Rossi; Saula Checquolo; Francesca Lepri; Viviana Caputo; Marianna Silvano; Francesco Buscherini; Federica Consoli; Grazia Ferrara; Maria C Digilio; Maria L Cavaliere; Johanna M van Hagen; Giuseppe Zampino; Ineke van der Burgt; Giovanni B Ferrero; Laura Mazzanti; Isabella Screpanti; Helger G Yntema; Willy M Nillesen; Ravi Savarirayan; Martin Zenker; Bruno Dallapiccola; Bruce D Gelb; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2010-07-08       Impact factor: 11.025

3.  Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.

Authors:  Kathryn A Stern; Gina D Visser Smit; Trenton L Place; Stanley Winistorfer; Robert C Piper; Nancy L Lill
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

4.  c-Cbl tyrosine kinase-binding domain mutant G306E abolishes the interaction of c-Cbl with CD38 and fails to promote retinoic acid-induced cell differentiation and G0 arrest.

Authors:  Miaoqing Shen; Andrew Yen
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

5.  Abi-1 forms an epidermal growth factor-inducible complex with Cbl: role in receptor endocytosis.

Authors:  Barbara E Tanos; Ann Marie Pendergast
Journal:  Cell Signal       Date:  2007-02-22       Impact factor: 4.315

6.  c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells.

Authors:  Miaoqing Shen; Andrew Yen
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

7.  EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.

Authors:  Kathryn A Stern; Trenton L Place; Nancy L Lill
Journal:  Biochem J       Date:  2008-03-15       Impact factor: 3.857

8.  Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.

Authors:  Osamu Kikuchi; Shinya Ohashi; Tomohisa Horibe; Masayuki Kohno; Yukie Nakai; Shin'ichi Miyamoto; Tsutomu Chiba; Manabu Muto; Koji Kawakami
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379

9.  Chlamydia-induced curvature of the host-cell plasma membrane is required for infection.

Authors:  Sebastian Hänsch; Dominik Spona; Gido Murra; Karl Köhrer; Agathe Subtil; Ana Rita Furtado; Stephan F Lichtenthaler; Bastian Dislich; Katja Mölleken; Johannes H Hegemann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-21       Impact factor: 11.205

10.  Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.

Authors:  Xin-Chun Zhao; Gui-Zhen Wang; Zhe-Sheng Wen; Yong-Chun Zhou; Qian Hu; Bin Zhang; Li-Wei Qu; San-Hui Gao; Jie Liu; Liang Ma; Yan-Fei Zhang; Chen Zhang; Hong Yu; Da-Lin Zhang; Min Wang; Chang-Li Wang; Yun-Chao Huang; Zhi-Hua Liu; Yong Zhao; Liang Chen; Guang-Biao Zhou
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.